News stories about Thermo Fisher Scientific (NYSE:TMO) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Thermo Fisher Scientific earned a coverage optimism score of 0.08 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 47.1301811550079 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the headlines that may have effected Accern Sentiment’s scoring:
Top Medical Stocks To Own Right Now: Arca Biopharma Inc.(ABIO)
- [By Paul Ausick]
ARCA biopharma Inc. (NASDAQ: ABIO) traded down nearly 80% Monday and posted a new 52-week low of $0.45 after closing Friday at $1.60. The stock’s 52-week high is $2.76. Volume was around 9 million, nearly 40 times the daily average of around 230,000. The company reported a poor result on a phase 2 trial of treatment for a certain kind of heart problem.
Top Medical Stocks To Own Right Now: Stryker Corporation(SYK)
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Stryker (SYK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Dan Caplinger]
Finally, shares of Boston Scientific sank 6%. The medical device maker had jumped earlier in the week on reports that it might receive a takeover bid from industry peer Stryker (NYSE:SYK). Yet today, Stryker denied that it had been in acquisition talks with Boston Scientific, throwing cold water on the idea. With the downward push, Boston Scientific is now back to where the stock started the week before the reports surfaced in the first place. Boston Scientific will now apparently have to make the most of its own opportunities in the medical device space — at least unless another potential buyer comes around.
- [By Max Byerly]
State of Tennessee Treasury Department trimmed its stake in shares of Stryker Co. (NYSE:SYK) by 13.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 101,919 shares of the medical technology company’s stock after selling 16,340 shares during the period. State of Tennessee Treasury Department’s holdings in Stryker were worth $16,401,000 at the end of the most recent reporting period.
Top Medical Stocks To Own Right Now: Penumbra, Inc.(PEN)
- [By Logan Wallace]
Penumbra (NYSE:PEN) Director Bridget O’rourke purchased 700 shares of the business’s stock in a transaction that occurred on Friday, May 25th. The stock was bought at an average cost of $156.40 per share, for a total transaction of $109,480.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
- [By Stephan Byrd]
Penumbra (NYSE:PEN) released its quarterly earnings results on Tuesday. The company reported $0.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.08, Fidelity Earnings reports. Penumbra had a return on equity of 1.15% and a net margin of 3.65%. The business had revenue of $102.70 million for the quarter, compared to analysts’ expectations of $90.98 million. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. The company’s revenue was up 40.3% compared to the same quarter last year.